• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.Yap-Myc-Sox2-p53 调控网络决定了 Kras 驱动的胰腺导管腺癌中的代谢稳态和分化。
Dev Cell. 2019 Oct 7;51(1):113-128.e9. doi: 10.1016/j.devcel.2019.07.022. Epub 2019 Aug 22.
2
Yes-associated protein mediates immune reprogramming in pancreatic ductal adenocarcinoma.Yes相关蛋白介导胰腺导管腺癌中的免疫重编程。
Oncogene. 2017 Mar 2;36(9):1232-1244. doi: 10.1038/onc.2016.288. Epub 2016 Aug 22.
3
Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma.突变型 KRAS 下游的转录调节因子 YAP 对于胰腺导管腺癌的肿瘤进展是必需的。
Sci Signal. 2014 May 6;7(324):ra42. doi: 10.1126/scisignal.2005049.
4
Nicotine promotes initiation and progression of KRAS-induced pancreatic cancer via Gata6-dependent dedifferentiation of acinar cells in mice.尼古丁通过 Gata6 依赖性去分化胰腺腺泡细胞促进 KRAS 诱导的胰腺癌的发生和进展。
Gastroenterology. 2014 Nov;147(5):1119-33.e4. doi: 10.1053/j.gastro.2014.08.002. Epub 2014 Aug 12.
5
Lipophilic statins inhibit YAP nuclear localization, co-activator activity and colony formation in pancreatic cancer cells and prevent the initial stages of pancreatic ductal adenocarcinoma in KrasG12D mice.亲脂性他汀类药物抑制胰腺癌细胞中的 YAP 核定位、共激活剂活性和集落形成,并预防 KrasG12D 小鼠胰腺导管腺癌的早期阶段。
PLoS One. 2019 May 17;14(5):e0216603. doi: 10.1371/journal.pone.0216603. eCollection 2019.
6
A combinatorial strategy using YAP and pan-RAF inhibitors for treating KRAS-mutant pancreatic cancer.一种使用YAP和泛RAF抑制剂治疗KRAS突变型胰腺癌的联合策略。
Cancer Lett. 2017 Aug 28;402:61-70. doi: 10.1016/j.canlet.2017.05.015. Epub 2017 May 30.
7
KRAS, YAP, and obesity in pancreatic cancer: A signaling network with multiple loops.KRAS、YAP 和肥胖与胰腺癌:具有多个循环的信号网络。
Semin Cancer Biol. 2019 Feb;54:50-62. doi: 10.1016/j.semcancer.2017.10.007. Epub 2017 Oct 24.
8
Yap1 activation enables bypass of oncogenic Kras addiction in pancreatic cancer.Yap1 激活可绕过胰腺癌中的致癌 Kras 成瘾。
Cell. 2014 Jul 3;158(1):185-197. doi: 10.1016/j.cell.2014.06.003. Epub 2014 Jun 19.
9
YAP and AP-1 Cooperate to Initiate Pancreatic Cancer Development from Ductal Cells in Mice.YAP 和 AP-1 合作从小鼠的导管细胞起始胰腺癌的发生。
Cancer Res. 2020 Nov 1;80(21):4768-4779. doi: 10.1158/0008-5472.CAN-20-0907. Epub 2020 Sep 8.
10
Inhibiting NR5A2 targets stemness in pancreatic cancer by disrupting SOX2/MYC signaling and restoring chemosensitivity.抑制 NR5A2 通过破坏 SOX2/MYC 信号和恢复化疗敏感性来靶向胰腺癌中的干性。
J Exp Clin Cancer Res. 2023 Nov 28;42(1):323. doi: 10.1186/s13046-023-02883-y.

引用本文的文献

1
The Hippo signaling pathway modulates pancreatic tissue homeostasis.河马信号通路调节胰腺组织稳态。
Cell Death Discov. 2025 Jul 24;11(1):343. doi: 10.1038/s41420-025-02636-0.
2
SOX2 regulates foregut squamous epithelial homeostasis and is lost during Barrett's esophagus development.SOX2调节前肠鳞状上皮稳态,并在巴雷特食管发展过程中缺失。
J Clin Invest. 2025 Jun 19;135(16). doi: 10.1172/JCI190374.
3
LDHA-mediated YAP lactylation promotes the tumor progression of hepatocellular carcinoma by inducing YAP dephosphorylation and activation.乳酸脱氢酶A(LDHA)介导的YAP乳酸化通过诱导YAP去磷酸化和激活来促进肝细胞癌的肿瘤进展。
Biol Direct. 2025 May 26;20(1):64. doi: 10.1186/s13062-025-00655-6.
4
AR and YAP crosstalk: impacts on therapeutic strategies in prostate cancer.雄激素受体(AR)与Yes相关蛋白(YAP)的相互作用:对前列腺癌治疗策略的影响
Front Oncol. 2025 Feb 3;15:1520808. doi: 10.3389/fonc.2025.1520808. eCollection 2025.
5
Positive feedback between arginine methylation of YAP and methionine transporter SLC43A2 drives anticancer drug resistance.YAP的精氨酸甲基化与甲硫氨酸转运蛋白SLC43A2之间的正反馈驱动抗癌药物耐药性。
Nat Commun. 2025 Jan 2;16(1):87. doi: 10.1038/s41467-024-55769-8.
6
GPRC5A promotes lung colonization of esophageal squamous cell carcinoma.GPRC5A 促进食管鳞癌细胞的肺定植。
Nat Commun. 2024 Nov 16;15(1):9950. doi: 10.1038/s41467-024-54251-9.
7
Differential miRNA and Protein Expression Reveals miR-1285, Its Targets TGM2 and CDH-1, as Well as CD166 and S100A13 as Potential New Biomarkers in Patients with Diabetes Mellitus and Pancreatic Adenocarcinoma.差异性miRNA和蛋白质表达揭示了miR-1285及其靶标TGM2和CDH-1,以及CD166和S100A13作为糖尿病和胰腺腺癌患者潜在的新型生物标志物。
Cancers (Basel). 2024 Jul 31;16(15):2726. doi: 10.3390/cancers16152726.
8
Mitochondrial transfer in tunneling nanotubes-a new target for cancer therapy.线粒体在隧道纳米管中的转移——癌症治疗的新靶点。
J Exp Clin Cancer Res. 2024 May 21;43(1):147. doi: 10.1186/s13046-024-03069-w.
9
Role of Hippo pathway dysregulation from gastrointestinal premalignant lesions to cancer.Hippo 通路失调在胃肠道前恶性病变向癌症发展中的作用。
J Transl Med. 2024 Feb 29;22(1):213. doi: 10.1186/s12967-024-05027-8.
10
TEAD Inhibition Overcomes YAP1/TAZ-Driven Primary and Acquired Resistance to KRASG12C Inhibitors.TEAD 抑制克服了 YAP1/TAZ 驱动的 KRASG12C 抑制剂的原发性和获得性耐药。
Cancer Res. 2023 Dec 15;83(24):4112-4129. doi: 10.1158/0008-5472.CAN-23-2994.

本文引用的文献

1
YAP/TAZ Inhibition Induces Metabolic and Signaling Rewiring Resulting in Targetable Vulnerabilities in NF2-Deficient Tumor Cells.YAP/TAZ 抑制诱导代谢和信号重排,导致 NF2 缺陷肿瘤细胞中可靶向的脆弱性。
Dev Cell. 2019 May 6;49(3):425-443.e9. doi: 10.1016/j.devcel.2019.04.014.
2
The complex entanglement of Hippo-Yap/Taz signaling in tumor immunity.Hippo-Yap/Taz 信号在肿瘤免疫中的复杂纠缠。
Oncogene. 2019 Apr;38(16):2899-2909. doi: 10.1038/s41388-018-0649-6. Epub 2019 Jan 7.
3
Epithelial-to-mesenchymal transition in cancer: complexity and opportunities.癌症中的上皮-间充质转化:复杂性和机遇。
Front Med. 2018 Aug;12(4):361-373. doi: 10.1007/s11684-018-0656-6. Epub 2018 Jul 24.
4
Yes-associated protein (YAP) in pancreatic cancer: at the epicenter of a targetable signaling network associated with patient survival.Yes 相关蛋白(YAP)在胰腺癌中的作用:位于与患者生存相关的可靶向信号网络的中心。
Signal Transduct Target Ther. 2018 Apr 20;3:11. doi: 10.1038/s41392-017-0005-2. eCollection 2018.
5
The Role of Hippo Pathway in Cancer Stem Cell Biology.Hippo 通路在癌症干细胞生物学中的作用。
Mol Cells. 2018 Feb 28;41(2):83-92. doi: 10.14348/molcells.2018.2242. Epub 2018 Feb 5.
6
Mutant p53R270H drives altered metabolism and increased invasion in pancreatic ductal adenocarcinoma.突变型 p53R270H 驱动胰腺导管腺癌代谢改变和侵袭增强。
JCI Insight. 2018 Jan 25;3(2). doi: 10.1172/jci.insight.97422.
7
Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes.进化途径和 KRAS 剂量决定胰腺癌细胞表型。
Nature. 2018 Feb 1;554(7690):62-68. doi: 10.1038/nature25459. Epub 2018 Jan 24.
8
Hedgehog-YAP Signaling Pathway Regulates Glutaminolysis to Control Activation of Hepatic Stellate Cells.刺猬-YAP 信号通路调控谷氨酰胺代谢以控制肝星状细胞的激活。
Gastroenterology. 2018 Apr;154(5):1465-1479.e13. doi: 10.1053/j.gastro.2017.12.022. Epub 2018 Jan 3.
9
The receptor tyrosine kinase EphA2 promotes glutamine metabolism in tumors by activating the transcriptional coactivators YAP and TAZ.受体酪氨酸激酶 EphA2 通过激活转录共激活因子 YAP 和 TAZ 促进肿瘤中的谷氨酰胺代谢。
Sci Signal. 2017 Dec 5;10(508):eaan4667. doi: 10.1126/scisignal.aan4667.
10
Glut3 Addiction Is a Druggable Vulnerability for a Molecularly Defined Subpopulation of Glioblastoma.谷氨酰胺转运体3成瘾是胶质母细胞瘤分子定义亚群的一个可药物靶向的脆弱点。
Cancer Cell. 2017 Dec 11;32(6):856-868.e5. doi: 10.1016/j.ccell.2017.10.016. Epub 2017 Nov 30.

Yap-Myc-Sox2-p53 调控网络决定了 Kras 驱动的胰腺导管腺癌中的代谢稳态和分化。

A Yap-Myc-Sox2-p53 Regulatory Network Dictates Metabolic Homeostasis and Differentiation in Kras-Driven Pancreatic Ductal Adenocarcinomas.

机构信息

Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.

Institut National de la Santé et de la Recherche Médicale (INSERM) U1151, Institut Necker Enfants Malades, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

出版信息

Dev Cell. 2019 Oct 7;51(1):113-128.e9. doi: 10.1016/j.devcel.2019.07.022. Epub 2019 Aug 22.

DOI:10.1016/j.devcel.2019.07.022
PMID:31447265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6783361/
Abstract

Employing inducible genetically engineered and orthotopic mouse models, we demonstrate a key role for transcriptional regulator Yap in maintenance of Kras-mutant pancreatic tumors. Integrated transcriptional and metabolomics analysis reveals that Yap transcribes Myc and cooperates with Myc to maintain global transcription of metabolic genes. Yap loss triggers acute metabolic stress, which causes tumor regression while inducing epigenetic reprogramming and Sox2 upregulation in a subset of pancreatic neoplastic cells. Sox2 restores Myc expression and metabolic homeostasis in Yap-deficient neoplastic ductal cells, which gradually re-differentiate into acinar-like cells, partially restoring pancreatic parenchyma in vivo. Both the short-term and long-term effects of Yap loss in inducing cell death and re-differentiation, respectively, are blunted in advanced, poorly differentiated p53-mutant pancreatic tumors. Collectively, these findings reveal a highly dynamic and interdependent metabolic, transcriptional, and epigenetic regulatory network governed by Yap, Myc, Sox2, and p53 that dictates pancreatic tumor metabolism, growth, survival, and differentiation.

摘要

利用可诱导的基因工程和原位小鼠模型,我们证明了转录调节剂 Yap 在维持 Kras 突变的胰腺肿瘤中起着关键作用。综合转录组学和代谢组学分析表明, Yap 转录 Myc,并与 Myc 合作维持代谢基因的全局转录。 Yap 的缺失会引发急性代谢应激,导致肿瘤消退,同时在一部分胰腺肿瘤细胞中诱导表观遗传重编程和 Sox2 的上调。Sox2 在 Yap 缺陷的肿瘤导管细胞中恢复 Myc 的表达和代谢平衡,这些细胞逐渐重新分化为腺泡样细胞,在体内部分恢复胰腺实质。在诱导细胞死亡和重新分化方面,分别在晚期、分化不良的 p53 突变胰腺肿瘤中, Yap 缺失的短期和长期效应均减弱。总的来说,这些发现揭示了一个由 yap、Myc、Sox2 和 p53 控制的高度动态和相互依存的代谢、转录和表观遗传调控网络,该网络决定了胰腺肿瘤的代谢、生长、存活和分化。